Stalemate. They announced the progress of specific clinical research using the at-home and remote ophthalmic retinal monitoring device "eyeMO". In a specific clinical study being conducted at Shinshu University School of Medicine Affiliated Hospital, the results of feasibility confirmation of the device have transitioned to the step of evaluating the potential for patients to use this device for monitoring at home. Rental income is expected from this specific clinical research. However, it is currently difficult to objectively calculate the consolidated performance forecast for the year ending December 2024, and thus the full-year performance forecast disclosure has been postponed.